Market Cap

Formosa Laboratories, Inc. Market Capitalization:

TW$12.38 Billion

TWD as of July 1, 2024

US$380.3 Million

business Formosa Laboratories, Inc. Company Profile

Formosa Laboratories, Inc. Main Stock Listing

TWSE: 4746

Market Capitalization History of Formosa Laboratories, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Formosa Laboratories, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$13.58 B 68.04%
Jan. 1, 2023 TW$8.08 B 23.53%
Jan. 1, 2022 TW$6.54 B 15.87%
Jan. 1, 2021 TW$5.65 B 12.32%
Jan. 1, 2020 TW$5.03 B 5.03%
Jan. 1, 2019 TW$4.79 B -30.21%
Jan. 1, 2018 TW$6.86 B -41.39%
Jan. 1, 2017 TW$11.70 B 41.45%
Jan. 1, 2015 TW$8.27 B -4.56%
Jan. 1, 2014 TW$8.67 B 53.14%
Jan. 1, 2013 TW$5.66 B -36.77%
Jan. 1, 2012 TW$8.95 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Formosa Laboratories, Inc. Categories

Taiwan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Taiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic

Stocks & Indices

Formosa Laboratories, Inc. has the following listings and related stock indices.


Stock: TWSE: 4746

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.